A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance.
Basso
Michele
M
Cassano
Alessandra
A
Modoni
Anna
A
Spada
Daniele
D
Trigila
Nunziatina
N
Quirino
Michela
M
Schinzari
Giovanni
G
Barone
Carlo
C
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003128:Coma / Q000139:chemically induced*; D004573:Electrolytes / Q000097:blood*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D004573:Electrolytes; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin